Tobias Bollenbach
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tobias Bollenbach has a total of 114 co-authors. Here are the top co-authors by number of shared publications:
- Periklis Pantazis
Department of Bioengineering, Imperial College London, London, UK
8 shared publications - Gerrit Ansmann
Institute for Biological Physics, University of Cologne, 50931 Cologne, Germany
7 shared publications - Frank Jülicher
Max Planck Institute for the Physics of Complex Systems
6 shared publications - Gašper Tkačik
Institute of Science and Technology Austria, AT-3400 Klosterneuburg, Austria
6 shared publications - Marcos González-Gaitán
Department of Biochemistry, Faculty of Sciences, University of Geneva, Geneva, Switzerland
6 shared publications Janina Müller
5 shared publications
Latest Publications
- Open Access
- 26 August 2026
- Published by Elsevier in Cell Systems
- Vol. 17 (10)
Ultrasensitive fitness costs arise from membrane proteome displacement under protein overexpression
- 26 August 2026
- Published by Elsevier in Cell Systems
- Vol. 17 (10)
Open AccessUltrasensitive fitness costs arise from membrane proteome displacement under protein overexpression
- Open Access
A generalized growth law for translation- and transcription-targeting antibiotics captures drug interactions
Bacterial growth laws quantitatively connect intracellular resource allocation to growth rate, enabling accurate predictions of physiology and antibiotic responses. Yet these laws have been rigorously tested for only a handful of perturbations. Here, we show that the growth law linking ribosome levels to growth rate under translation-inhibiting antibiotics is not universal, but rather depends on the antibiotic’s mechanism of action. Quantitative proteomics across finely resolved one- and two-dimensional antibiotic gradients showed that inhibitors of translocation elongation or peptide bond formation elicit the canonical rise in ribosome levels, consistent with the growth law. By contrast, antibiotics disrupting translation initiation or fidelity produced distinct responses without ribosome upregulation. The transcription inhibitor rifampicin even reduced ribosome abundance. Combining antibiotics with divergent ribosome responses revealed a generalized growth law, in which the individual responses to perturbations superimpose. Embedding this law in a mathematical model explains distinct drug interaction patterns observed between rifampicin and different translation inhibitors. A low-dimensional structure pervades the entire proteome, enabling prediction of responses to drug pairs based on single-drug measurements. Together, these findings broaden the scope of bacterial growth laws and provide new principles for predicting responses to antibiotic combinations.
Open AccessA generalized growth law for translation- and transcription-targeting antibiotics captures drug interactions
Bacterial growth laws quantitatively connect intracellular resource allocation to growth rate, enabling accurate predictions of physiology and antibiotic responses. Yet these laws have been rigorously tested for only a handful of perturbations. Here, we show that the growth law linking ribosome levels to growth rate under translation-inhibiting antibiotics is not universal, but rather depends on the antibiotic’s mechanism of action. Quantitative proteomics across finely resolved one- and two-dimensional antibiotic gradients showed that inhibitors of translocation elongation or peptide bond formation elicit the canonical rise in ribosome levels, consistent with the growth law. By contrast, antibiotics disrupting translation initiation or fidelity produced distinct responses without ribosome upregulation. The transcription inhibitor rifampicin even reduced ribosome abundance. Combining antibiotics with divergent ribosome responses revealed a generalized growth law, in which the individual responses to perturbations superimpose. Embedding this law in a mathematical model explains distinct drug interaction patterns observed between rifampicin and different translation inhibitors. A low-dimensional structure pervades the entire proteome, enabling prediction of responses to drug pairs based on single-drug measurements. Together, these findings broaden the scope of bacterial growth laws and provide new principles for predicting responses to antibiotic combinations.
- Open Access
- 28 July 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 7564
Function-specific epistasis shapes evolutionary trajectories towards antibiotic resistance
Pre-existing mutations can influence subsequent evolution by constraining or opening evolutionary pathways through epistatic interactions. In some cases, global epistasis allows evolutionary pathways to be predicted from the fitness of the genetic background alone. In other cases, idiosyncratic epistasis makes evolution less predictable. Here, we show that the evolution of antibiotic resistance is highly repeatable, following a common path across most genetic backgrounds. However, a minority of genetic backgrounds exhibit evolutionary trajectories that significantly deviate from this common path. Rather than being predictable from global epistasis, these deviations are modulated by function-specific epistasis: perturbations to specific cellular functions lead to novel evolutionary trajectories towards resistance. Using tightly controlled robotic evolution experiments, we quantitatively analyzed resistance trajectories for three clinically relevant antibiotics across multiple genetic backgrounds, including hundreds of Escherichia coli gene-deletion strains and several clinical isolates from urinary-tract infections. We show that disrupting distinct sets of cellular functions alters evolutionary trajectories for specific drugs and across different drugs, and we identify genetic changes defining these alternative trajectories. Importantly, this function-specific epistasis often slows down resistance evolution. Some of these effects can also be induced by small-molecule inhibitors of the identified targets, suggesting that function-specific epistasis can be exploited to improve drug treatments.
- 28 July 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 7564
Open AccessFunction-specific epistasis shapes evolutionary trajectories towards antibiotic resistance
Pre-existing mutations can influence subsequent evolution by constraining or opening evolutionary pathways through epistatic interactions. In some cases, global epistasis allows evolutionary pathways to be predicted from the fitness of the genetic background alone. In other cases, idiosyncratic epistasis makes evolution less predictable. Here, we show that the evolution of antibiotic resistance is highly repeatable, following a common path across most genetic backgrounds. However, a minority of genetic backgrounds exhibit evolutionary trajectories that significantly deviate from this common path. Rather than being predictable from global epistasis, these deviations are modulated by function-specific epistasis: perturbations to specific cellular functions lead to novel evolutionary trajectories towards resistance. Using tightly controlled robotic evolution experiments, we quantitatively analyzed resistance trajectories for three clinically relevant antibiotics across multiple genetic backgrounds, including hundreds of Escherichia coli gene-deletion strains and several clinical isolates from urinary-tract infections. We show that disrupting distinct sets of cellular functions alters evolutionary trajectories for specific drugs and across different drugs, and we identify genetic changes defining these alternative trajectories. Importantly, this function-specific epistasis often slows down resistance evolution. Some of these effects can also be induced by small-molecule inhibitors of the identified targets, suggesting that function-specific epistasis can be exploited to improve drug treatments.
- Open Access
- 15 July 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (29)
Contributions of intra- and extracellular antibiotic degradation to collective [Formula: see text]-lactam survival.
Collective antibiotic resistance occurs when populations of bacteria survive antibiotic treatments that are lethal to individual bacteria, which affects the efficacy of drug therapies. An important mechanism of collective resistance against widely used [Formula: see text]-lactams is the production of drug-degrading [Formula: see text]-lactamases. Here, we integrate experiments with mathematical modeling to understand the collective survival of Escherichia coli challenged with cefotaxime (CTX). At near-lethal CTX concentrations, we observe complex dynamics, involving initial biomass growth due to filamentation, followed by death, and subsequently growth recovery. We show that production of AmpC, a chromosomal [Formula: see text]-lactamase, is responsible for CTX degradation, allowing the resumption of cell division in surviving filaments. The detoxification of the environment proceeds through CTX hydrolysis by AmpC in the periplasm of intact cells, as well as extracellularly after cell lysis. Our model predicts the recovery time from molecular parameters, and quantifies the relative roles of periplasmic and extracellular degradation for two strains of E. coli that differ in the degree of privatization of AmpC hydrolysis. Our findings suggest that [Formula: see text]-lactam survival of bacterial infections depends on a combination of intra- and extracellular [Formula: see text]-lactamase activity, which will likely vary among isolates.
- 15 July 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (29)
Open AccessContributions of intra- and extracellular antibiotic degradation to collective [Formula: see text]-lactam survival.
Collective antibiotic resistance occurs when populations of bacteria survive antibiotic treatments that are lethal to individual bacteria, which affects the efficacy of drug therapies. An important mechanism of collective resistance against widely used [Formula: see text]-lactams is the production of drug-degrading [Formula: see text]-lactamases. Here, we integrate experiments with mathematical modeling to understand the collective survival of Escherichia coli challenged with cefotaxime (CTX). At near-lethal CTX concentrations, we observe complex dynamics, involving initial biomass growth due to filamentation, followed by death, and subsequently growth recovery. We show that production of AmpC, a chromosomal [Formula: see text]-lactamase, is responsible for CTX degradation, allowing the resumption of cell division in surviving filaments. The detoxification of the environment proceeds through CTX hydrolysis by AmpC in the periplasm of intact cells, as well as extracellularly after cell lysis. Our model predicts the recovery time from molecular parameters, and quantifies the relative roles of periplasmic and extracellular degradation for two strains of E. coli that differ in the degree of privatization of AmpC hydrolysis. Our findings suggest that [Formula: see text]-lactam survival of bacterial infections depends on a combination of intra- and extracellular [Formula: see text]-lactamase activity, which will likely vary among isolates.
- Open Access
- 26 June 2026
- Published by Elsevier in Cell Host & Microbe
- Vol. 34 (7) , 1186-1201
Predicting antimicrobial resistance for precision medicine
- 26 June 2026
- Published by Elsevier in Cell Host & Microbe
- Vol. 34 (7) , 1186-1201
Open AccessPredicting antimicrobial resistance for precision medicine
- Open Access
A competition-protection balance explains the evolution of resistance within simple microbial communities
Stressful environments can pose a threat to microbial populations, but resistant individuals can emerge and avoid extinction. Adaptation to stress is classically studied in isolated microbial species, ignoring ecological interactions, a key component of natural ecosystems. A growing body of experimental work has shown that community context can affect resistance evolution due to a large variety of mechanisms. Here we set out to identify the minimal components needed to predict the likelihood of acquiring resistance in a focal species embedded within a simple community. To achieve this, we developed a mathematical model based on evolutionary rescue theory and validated it with two experimental systems: Escherichia coli evolving on exposure to the antibiotic nitrofurantoin alone or with one of 14 bacterial isolates from urinary tract infections, and Microbacterium liquefaciens evolving in ampicillin alone or with ampicillin-degrading Comamonas testosteroni . One key factor that emerged from our analyses — the relative strength of competition versus protection — could explain whether a focal species is more or less likely to evolve resistance in the presence of a partner species. While competition always hinders the emergence of resistance, protection can rescue the focal species in two ways: (i) ecological rescue, when the partner species completely removes the antibiotic and favors the survival of the susceptible population, or (ii) evolutionary rescue, when the partner only lowers antibiotic concentrations and favors the emergence of resistant variants, a previously overlooked evolutionary consequence of detoxification. Overall, by integrating theory and experiments, we propose a framework that clarifies how ecological interactions favor or hinder the evolution of resistance to antibiotics or potentially other stressors.
Open AccessA competition-protection balance explains the evolution of resistance within simple microbial communities
Stressful environments can pose a threat to microbial populations, but resistant individuals can emerge and avoid extinction. Adaptation to stress is classically studied in isolated microbial species, ignoring ecological interactions, a key component of natural ecosystems. A growing body of experimental work has shown that community context can affect resistance evolution due to a large variety of mechanisms. Here we set out to identify the minimal components needed to predict the likelihood of acquiring resistance in a focal species embedded within a simple community. To achieve this, we developed a mathematical model based on evolutionary rescue theory and validated it with two experimental systems: Escherichia coli evolving on exposure to the antibiotic nitrofurantoin alone or with one of 14 bacterial isolates from urinary tract infections, and Microbacterium liquefaciens evolving in ampicillin alone or with ampicillin-degrading Comamonas testosteroni . One key factor that emerged from our analyses — the relative strength of competition versus protection — could explain whether a focal species is more or less likely to evolve resistance in the presence of a partner species. While competition always hinders the emergence of resistance, protection can rescue the focal species in two ways: (i) ecological rescue, when the partner species completely removes the antibiotic and favors the survival of the susceptible population, or (ii) evolutionary rescue, when the partner only lowers antibiotic concentrations and favors the emergence of resistant variants, a previously overlooked evolutionary consequence of detoxification. Overall, by integrating theory and experiments, we propose a framework that clarifies how ecological interactions favor or hinder the evolution of resistance to antibiotics or potentially other stressors.
- Open Access
Function-specific epistasis shapes evolutionary trajectories towards antibiotic resistance
Pre-existing mutations can influence subsequent evolution by constraining or opening evolutionary pathways through epistatic interactions. In some cases, global epistasis allows evolutionary pathways to be predicted from the fitness of the genetic background alone. In other cases, idiosyncratic epistasis makes evolution less predictable. Here, we show that the evolution of antibiotic resistance is highly repeatable, following a common path across most genetic backgrounds. However, a minority of genetic backgrounds exhibit evolutionary trajectories that significantly deviate from this common path. Rather than being predictable from global epistasis, these deviations are modulated by function-specific epistasis: perturbations to specific cellular functions lead to novel evolutionary trajectories towards resistance. Using tightly controlled robotic evolution experiments, we quantitatively analyzed resistance trajectories for three clinically relevant antibiotics across multiple genetic backgrounds, including hundreds of Escherichia coli gene-deletion strains and several clinical isolates from urinary-tract infections. We show that disrupting distinct sets of cellular functions alters evolutionary trajectories for specific drugs and across different drugs, and we identify genetic changes defining these alternative trajectories. Importantly, this function-specific epistasis often slows down resistance evolution. Some of these effects can also be induced by small-molecule inhibitors of the identified targets, suggesting that function-specific epistasis can be exploited to improve drug treatments.
Open AccessFunction-specific epistasis shapes evolutionary trajectories towards antibiotic resistance
Pre-existing mutations can influence subsequent evolution by constraining or opening evolutionary pathways through epistatic interactions. In some cases, global epistasis allows evolutionary pathways to be predicted from the fitness of the genetic background alone. In other cases, idiosyncratic epistasis makes evolution less predictable. Here, we show that the evolution of antibiotic resistance is highly repeatable, following a common path across most genetic backgrounds. However, a minority of genetic backgrounds exhibit evolutionary trajectories that significantly deviate from this common path. Rather than being predictable from global epistasis, these deviations are modulated by function-specific epistasis: perturbations to specific cellular functions lead to novel evolutionary trajectories towards resistance. Using tightly controlled robotic evolution experiments, we quantitatively analyzed resistance trajectories for three clinically relevant antibiotics across multiple genetic backgrounds, including hundreds of Escherichia coli gene-deletion strains and several clinical isolates from urinary-tract infections. We show that disrupting distinct sets of cellular functions alters evolutionary trajectories for specific drugs and across different drugs, and we identify genetic changes defining these alternative trajectories. Importantly, this function-specific epistasis often slows down resistance evolution. Some of these effects can also be induced by small-molecule inhibitors of the identified targets, suggesting that function-specific epistasis can be exploited to improve drug treatments.
- Open Access
- 8 April 2025
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 23 (4) , e3003065
Extreme diversity of phage amplification rates and phage–antibiotic interactions revealed by PHORCE
Growth rate plays a fundamental role in microbiology and serves as an important proxy for fitness in evolution. While high-throughput measurements of bacterial growth rates are easily performed in any microbiology laboratory, similar methods are lacking for bacteriophages. This gap hinders systematic comparisons of important phage phenotypes, such as their amplification rate in bacterial populations and their bactericidal effect, across different phages and environmental conditions. Here, we show that the amplification rate of lytic phages can be quantified by analyzing bacterial population growth and collapse dynamics under phage predation using a parsimonious mathematical model – an approach termed Phage-Host Observation for Rate estimation from Collapse Events (PHORCE). We found that the resulting phage amplification rate captures the bactericidal effect independent of initial phage and bacterial population sizes for fast-growing hosts and adsorption-limited phages. Using high-throughput PHORCE, we found that the amplification rates of Escherichia coli phages vary widely by more than three orders of magnitude. Furthermore, our approach suggests that phage–antibiotic interactions are predominantly determined by the antibiotic, and not by the phage. In particular, the ribosome-inhibiting antibiotic doxycycline generally showed antagonism with phage amplification, whereas the DNA-damaging antibiotic nitrofurantoin was synergistic. This framework provides a means to quantitatively characterize phage phenotypes and may facilitate future high-throughput phage screens for antibacterial applications.
- 8 April 2025
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 23 (4) , e3003065
Open AccessExtreme diversity of phage amplification rates and phage–antibiotic interactions revealed by PHORCE
Growth rate plays a fundamental role in microbiology and serves as an important proxy for fitness in evolution. While high-throughput measurements of bacterial growth rates are easily performed in any microbiology laboratory, similar methods are lacking for bacteriophages. This gap hinders systematic comparisons of important phage phenotypes, such as their amplification rate in bacterial populations and their bactericidal effect, across different phages and environmental conditions. Here, we show that the amplification rate of lytic phages can be quantified by analyzing bacterial population growth and collapse dynamics under phage predation using a parsimonious mathematical model – an approach termed Phage-Host Observation for Rate estimation from Collapse Events (PHORCE). We found that the resulting phage amplification rate captures the bactericidal effect independent of initial phage and bacterial population sizes for fast-growing hosts and adsorption-limited phages. Using high-throughput PHORCE, we found that the amplification rates of Escherichia coli phages vary widely by more than three orders of magnitude. Furthermore, our approach suggests that phage–antibiotic interactions are predominantly determined by the antibiotic, and not by the phage. In particular, the ribosome-inhibiting antibiotic doxycycline generally showed antagonism with phage amplification, whereas the DNA-damaging antibiotic nitrofurantoin was synergistic. This framework provides a means to quantitatively characterize phage phenotypes and may facilitate future high-throughput phage screens for antibacterial applications.
- Open Access
Ultrasensitive fitness costs arise from membrane proteome displacement under protein overexpression
Protein overexpression is crucial in many diseases and can lead to antibiotic resistance by increasing the expression of drug targets or resistance genes, such as membrane-localized efflux pumps. Using a high-throughput colony-imaging technique, we performed a quantitative genome-wide study of protein overexpression in Escherichia coli . Our results show that most membrane proteins impose steep overexpression costs, leading to an abrupt growth collapse beyond a critical expression threshold. By manipulating synthetic membrane proteins to target different translocation pathways, we ruled out saturation of these pathways as the cause of these fitness costs. Instead, we found that the growth collapse is driven by the displacement of endogenous membrane proteins, which we show directly using single-cell time-lapse imaging with fluorescently tagged membrane proteins in a microfluidic device. Displacement of as little as 10% of the membrane proteome trapped most bacteria in a non-growing state. Our findings enhance the quantitative understanding of expression costs, with implications for antibiotic resistance and the biotechnological production of membrane proteins.
Open AccessUltrasensitive fitness costs arise from membrane proteome displacement under protein overexpression
Protein overexpression is crucial in many diseases and can lead to antibiotic resistance by increasing the expression of drug targets or resistance genes, such as membrane-localized efflux pumps. Using a high-throughput colony-imaging technique, we performed a quantitative genome-wide study of protein overexpression in Escherichia coli . Our results show that most membrane proteins impose steep overexpression costs, leading to an abrupt growth collapse beyond a critical expression threshold. By manipulating synthetic membrane proteins to target different translocation pathways, we ruled out saturation of these pathways as the cause of these fitness costs. Instead, we found that the growth collapse is driven by the displacement of endogenous membrane proteins, which we show directly using single-cell time-lapse imaging with fluorescently tagged membrane proteins in a microfluidic device. Displacement of as little as 10% of the membrane proteome trapped most bacteria in a non-growing state. Our findings enhance the quantitative understanding of expression costs, with implications for antibiotic resistance and the biotechnological production of membrane proteins.
- Open Access
- 1 January 2025
- Published by The Royal Society in Open Biology
- Vol. 15 (1) , 240301
Trace elements increase replicability of microbial growth
Trace elements are often omitted from chemically defined growth media. From established properties of trace elements, we deduce that this omission makes experiments unnecessarily sensitive to unavoidable contamination with trace elements. We confirm this experimentally by growing 11 bacterial strains in high replicate with and without supplementing trace elements, keeping all other conditions as fixed as possible to isolate the effect of trace elements. We find that supplementing trace elements considerably reduces variability of growth even in this benign scenario, and we argue that typical experimental set-ups exacerbate this. We discuss implications for the design and use of trace-element supplements and in particular argue that their use should be standard practice, as they can reduce variability of almost all experiments using chemically defined media, taking a step towards greater precision and replicability in microbiology.
- 1 January 2025
- Published by The Royal Society in Open Biology
- Vol. 15 (1) , 240301
Open AccessTrace elements increase replicability of microbial growth
Trace elements are often omitted from chemically defined growth media. From established properties of trace elements, we deduce that this omission makes experiments unnecessarily sensitive to unavoidable contamination with trace elements. We confirm this experimentally by growing 11 bacterial strains in high replicate with and without supplementing trace elements, keeping all other conditions as fixed as possible to isolate the effect of trace elements. We find that supplementing trace elements considerably reduces variability of growth even in this benign scenario, and we argue that typical experimental set-ups exacerbate this. We discuss implications for the design and use of trace-element supplements and in particular argue that their use should be standard practice, as they can reduce variability of almost all experiments using chemically defined media, taking a step towards greater precision and replicability in microbiology.